Topaz TTVR System
Severe Tricuspid Regurgitation (TR)
PivotalActive
Key Facts
About TRiCares
TRiCares is a private, clinical-stage medical device company focused on revolutionizing the treatment of tricuspid regurgitation (TR) with its Topaz transcatheter valve replacement system. The company is actively conducting pivotal studies in the EU and an early feasibility study in the US, supported by substantial venture funding and a recent €20 million loan from the European Investment Bank. With a seasoned leadership team and a large, underserved patient population, TRiCares is positioning itself as a key player in the emerging transcatheter tricuspid intervention market.
View full company profileTherapeutic Areas
Other Severe Tricuspid Regurgitation (TR) Drugs
| Drug | Company | Phase |
|---|---|---|
| TTVR System | Laplace Interventional | Investigational / Pre-clinical |